NCT00819169View on ClinicalTrials.gov

QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

January 16, 2009

Primary Completion Date

August 10, 2011

Study Completion Date

August 10, 2011

Conditions
Colorectal CancerLocally AdvancedMetastatic CancerNon-Small Cell Lung CancerOvarian CancerPancreatic CancerSarcomaSolid Tumors
Interventions
BIOLOGICAL

AMG 479

AMG 479 is an investigational, fully human, monoclonal antibody that binds with Insulin-like growth factor receptor type 1.

BIOLOGICAL

AMG 655

AMG 655 is an investigational, fully human, monoclonal antibody that binds with TNF-related apoptosis-inducing ligand, DR 5.

Sponsors

Lead Sponsor

NantCell, Inc.
All Listed Sponsors
lead

NantCell, Inc.

INDUSTRY

NCT00819169 - QUILT-3.026: AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors | Biotech Hunter | Biotech Hunter